Brinson Patrick Expands Equity Research Department with Addition of Senior Analyst Vernon Bernardino

- Bernardino Brings 11 Years of Experience Covering
Life Sciences Companies to Investment Bank -

View PDF »
Return to News »

NEW YORK, Sept. 5, 2012 – Brinson Patrick Securities Corporation, a boutique investment bank specializing in at-the-market (ATM) offerings, today announced the expansion of its equity research department with the addition of Vernon Bernardino as a senior research analyst focused on life sciences companies. Bernardino, who is based in the firm’s New York City office, brings to Brinson Patrick 11 years of experience covering biotechnology and pharmaceutical companies for Dawson James Securities, Rodman & Renshaw and UBS.

“Our equity research department has made steady progress since being formed at the start of the year, and Vernon joining the team is another strong step forward for us,” said Todd Wyche, CEO of Brinson Patrick. “In addition to his 11 years of experience covering life sciences companies, Vernon brings 12 years of biopharmaceutical drug discovery research experience. We believe leveraging this experience in equity research positions him to provide deep insights into the businesses that he covers and look forward to having him as part of our team.”

In his previous analyst roles, Bernardino specialized in covering companies that focus on investigational small molecule drugs, immunotherapies targeting cancer and infectious diseases, and cell-based therapies targeting inflammatory disorders, vascular diseases and cancer. He also held a position as a buy-side analyst at Nicholas Applegate Capital Management and founded the strategic advisory group Oceros Advisors. Bernardino began his career in research positions with Corvas International, which was acquired by Dendreon, and Schering-Plough.

About At-the-Market (ATM) Offerings

ATMs provide an efficient means of raising equity capital over time, making them ideal for raising general working capital, funding specific projects, funding research and development and paying off debt. ATMs provide flexibility, efficiency, control, discretion and just-in-time capital with minimal dilution of stock when managed by an experienced ATM underwriter. With an ATM, an exchange-listed company incrementally sells newly issued shares into the trading market through a designated broker-dealer at prevailing market prices, rather than via a traditional underwritten offering of a fixed number of shares at a fixed price all at once. ATMs enable publicly traded companies to tap into the existing secondary market for shares on an as-needed basis.

About Brinson Patrick Securities Corporation

Brinson Patrick Securities Corporation is a boutique investment bank that employs its DOCS® (Dynamic Offering of Common Stock) at-the-market (ATM) financing facility to raise the capital for clients as they need it. The DOCS® ATM is a low-profile equity offering appropriate for publicly traded companies across multiple industries and market capitalizations. It has been successfully utilized by companies in the energy, life science, technology, real estate, financial services and hospitality industries with market capitalizations that range from $50 million to over $1 billion.

Brinson Patrick’s offices are located in New York City and Newport Beach, Calif. For more information about ATMs and the firm, visit http://www.brinsonpatrick.com.

Brinson Patrick is a FINRA member broker-dealer.

EDITOR’S NOTE: Photograph of Vernon Bernardino available on request.

Media Contacts:
David Schull or Ian Stone
Russo Partners
(858) 717-2310
(619) 308-6541